COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,952 Articles (22,604 medRxiv, 8,348 bioRxiv)

Most recent first Previous |  Page 2616: Articles 26151-26160  | Next

Are antibodies tests accurate? Understanding predictive values and uncertainty of serology tests for the novel coronavirus.
Brownstein, N. C., Chen, Y. A.
10.1101/2020.06.04.20122358 — Posted: 2020-06-05
Covid-19: analysis of a modified SEIR model, a comparison of different intervention strategies and projections for India
Das, A., Dhar, A., Kundu, A., Goyal, S.
10.1101/2020.06.04.20122580 — Posted: 2020-06-05
Anemia and iron metabolism in COVID-19: A systematic review and meta-analysis
Taneri, P. E., Gomez-Ochoa, S. A., Llanaj, E., Raguindin, P. F., Rojas, L. Z., Wyssmann, B. M., Kopp-Heim, D., Hautz, W. E., Eisenga, M. F., Franco, O. H., Glisic, M., Muka, T.
10.1101/2020.06.04.20122267 — Posted: 2020-06-05
FAST: a Feasible, Accurate and Speedy Test Strategy for COVID-19
Fang, L., Ling, S., Jing, B.-Y., Yang, Q.
10.1101/2020.06.04.20122473 — Posted: 2020-06-05 Discussion: Onsite
Effect of gamma sterilization on filtering efficiency of various respiratory face-masks
Kumar, A., Saneetha, D. N., Yuvaraj, R., Menaka, M., Subramanian, V., Venkatraman, B.
10.1101/2020.06.04.20121830 — Posted: 2020-06-05 Discussion: Onsite
Applying a Prospective Space-Time Scan Statistic to Examine the Evolution of COVID-19 Clusters in the State of Sao Paulo, Brazil
Ferreira, R. V., Martines, M. R., Toppa, R. H., Assuncao, L. M., Desjardins, M. R., Delmelle, E. M.
10.1101/2020.06.04.20122770 — Posted: 2020-06-05 Discussion: Onsite
Optimal Control Measures to Combat COVID19 Spread in Sri Lanka: A Mathematical ModelConsidering the Heterogeneity of Cases
Wickramaarachchi, T., Perera, S.
10.1101/2020.06.04.20122382 — Posted: 2020-06-05
What variables can better predict the number of infections and deaths worldwide by SARS-CoV-2? Variation through time
Garcia de Alcaniz, J. G., Romero-Lopez, J., Martinez, R. P., Lopez-Rodas, V., Costas, E.
10.1101/2020.06.04.20122176 — Posted: 2020-06-05
ACE2 levels are altered in comorbidities linked to severe outcome in COVID-19
Emilsson, V., Gudmundsson, E. F., Aspelund, T., Jonsson, B. G., Gudjonsson, A., Launer, L. J., Lamb, J. R., Gudmundsdottir, V., Jennings, L. L., Gudnason, V.
10.1101/2020.06.04.20122044 — Posted: 2020-06-05
Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory-confirmed COVID-19 cases
Yannouchos, T., Sussman, R., Mier, J. M., Poulas, K., Farsalinos, K.
10.1101/2020.06.04.20122481 — Posted: 2020-06-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).